emerg
middl
east
respiratori
syndrom
coronaviru
merscov
late
caus
signific
global
public
clinic
concern
due
diseas
high
case
fatal
rate
inabl
distinguish
case
merscov
sever
respiratori
tract
infect
caus
pathogen
one
studi
found
monocytosi
normal
wbc
lower
creactiv
protein
crp
use
predictor
merscov
infect
clinic
present
mer
vari
asymptomat
sever
bilater
pneumonia
depend
case
definit
surveil
strategi
case
fatal
rate
merscov
chang
last
year
depend
outbreak
time
comprehens
surveil
program
includ
mild
asymptomat
case
countri
report
lower
case
fatal
rate
report
merscov
refer
center
riyadh
saudi
arabia
south
korea
outbreak
compar
sever
respiratori
infect
caus
nonmercov
case
fatal
rate
higher
mer
nonmer
case
six
year
merscov
epidem
studi
address
clinic
predictor
mortal
merscov
case
merscov
caus
concern
among
travel
howev
merscov
infect
report
infrequ
among
pilgrim
perform
umrah
report
travelrel
merscov
case
singl
case
travel
associ
merscov
infect
caus
largest
outbreak
outsid
arabian
peninsula
south
korea
systemat
review
pilgrim
acquisit
merscov
limit
systemat
screen
pilgrim
show
infect
asymptomat
merscov
case
among
travel
despit
high
proport
nontravel
recent
studi
includ
confirm
case
admit
hospit
found
independ
predictor
surviv
younger
age
transfer
icu
receiv
renal
replac
therapi
evalu
larger
number
case
longer
period
time
symptomat
merscov
confirm
patient
admit
referr
hospit
central
part
saudi
arabia
april
march
includ
studi
asymptomat
case
n
exclud
princ
moham
bin
abdulaziz
hospit
pmah
referr
center
merscov
patient
diagnos
central
region
base
riyadh
saudi
arabia
infect
confirm
use
real
time
rtpcr
respiratori
sampl
describ
previous
data
follow
paramet
collect
demograph
data
age
gender
height
weight
clinic
presenc
short
breath
cough
sore
throat
fever
laboratori
result
wbc
hemoglobin
platelet
neutrophil
hepat
function
test
alt
ast
creatinin
albumin
medic
intervent
plasmapheresi
use
intraven
immunoglobulin
extra
corpor
mechan
oxygen
ecmo
continu
renal
replac
therapi
crrt
interferonribavirin
corticosteroid
use
statist
analysi
done
use
minitab
minitab
inc
version
pa
usa
descript
analys
use
demograph
clinic
laboratori
data
bivari
analysi
describ
associ
statu
outcom
variou
clinic
laboratori
paramet
util
binari
logist
regress
analysi
backward
stepwis
approach
analyz
outcom
relat
continu
categor
variabl
odd
ratio
calcul
significantli
associ
variabl
pvalu
less
indic
statist
signific
total
symptomat
mer
patient
includ
analysi
mean
age
year
case
die
tabl
show
identifi
paramet
associ
mortal
binari
logist
regress
analysi
backward
stepwis
approach
follow
paramet
associ
increas
mortal
age
increas
wbc
neutrophil
count
lower
serum
albumin
level
use
crrt
corticosteroid
use
odd
ratio
mortal
highest
crrt
corticosteroid
use
respect
use
interferonribavirin
associ
mortal
cohort
major
patient
receiv
methylprednison
variabl
dose
durat
see
tabl
studi
analyz
predictor
mer
surviv
among
cohort
patient
admit
referr
center
merscov
therapi
capit
citi
riyadh
saudi
arabia
studi
includ
symptomat
case
analysi
asymptomat
case
recov
reason
exclus
attempt
investig
factor
contribut
mortal
symptomat
case
previou
studi
mild
asymptomat
diseas
observ
secondari
case
young
patient
previous
healthi
individu
describ
percentag
asymptomat
patient
increas
case
fatal
rate
decreas
symptomat
mer
patient
die
rate
lower
previous
publish
rang
earlier
studi
show
high
case
fatal
rate
among
symptomat
critic
ill
patient
studi
found
predictor
mortal
merscov
patient
increas
age
predictor
agreement
previou
studi
age
year
associ
increas
mortal
howev
studi
age
predictor
mortal
older
age
may
associ
concurr
comorbid
thu
increas
case
fatal
rate
one
studi
predictor
mortal
includ
older
age
nonhealthcar
worker
preexist
ill
sever
ill
hospitalacquir
infect
found
corticosteroid
associ
increas
mortal
one
studi
patient
receiv
corticosteroid
higher
crude
mortal
compar
among
compar
group
studi
author
compar
mer
patient
corticosteroid
group
deriv
differ
healthcar
facil
patient
receiv
corticosteroid
therapi
delay
clearanc
viral
rna
probabl
practic
use
corticosteroid
patient
show
clinic
improv
thu
might
higher
rate
mortal
begin
baselin
data
show
deceas
patient
higher
initi
wbc
compar
p
lower
hemoglobin
level
gdl
compar
surviv
gdl
p
addit
deceas
mer
case
lower
albumin
level
compar
surviv
group
p
similarli
previou
studi
show
low
serum
albumin
associ
sever
merscov
infect
may
reflect
nutrit
statu
patient
found
crrt
associ
higher
rate
mortal
among
mer
patient
previou
studi
applic
crrt
risk
factor
merscovrel
mortal
anoth
studi
show
mer
patient
like
requir
ecmo
vs
p
howev
one
studi
show
ecmo
group
lower
inhospit
mortal
vs
p
thu
suggest
ecmo
therapi
could
use
rescu
therapi
merscov
patient
develop
refractori
hypoxia
therapi
need
special
center
conclus
yet
know
factor
contribut
mortal
simpli
marker
premort
last
intervent
